Patents
A strong intellectual property portfolio supports Hybrid Organ's technology
covering the entire hybrid organ therapy value chain. The patent
coverage ensures key positions in tissue engineering and hybrid organs
in medicine, analytical reactors, substance producing reactors and cell
producing reactors.
The following patents cover legitimate claims on bioreactor constructions,
manufacturing processes and applications:
* Gerlach J.: German Patent 4230194: 9.9.92
* Gerlach J.: 7 European Patents: 93114076.8: 2.9.1993
* Gerlach J.: Japanese Patent Aplication 6-205665
* Gerlach J.: US Patent Application 08/117,429: 9.7.93
|